1. Home
  2. CVGI vs ATYR Comparison

CVGI vs ATYR Comparison

Compare CVGI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$1.71

Market Cap

59.5M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.90

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
ATYR
Founded
2000
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
69.2M
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
CVGI
ATYR
Price
$1.71
$0.90
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$4.20
AVG Volume (30 Days)
125.6K
2.5M
Earning Date
03-09-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$657,532,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.64
52 Week High
$2.15
$7.29

Technical Indicators

Market Signals
Indicator
CVGI
ATYR
Relative Strength Index (RSI) 48.03 56.40
Support Level $1.57 $0.82
Resistance Level $1.76 $0.94
Average True Range (ATR) 0.11 0.09
MACD 0.00 0.01
Stochastic Oscillator 37.31 58.42

Price Performance

Historical Comparison
CVGI
ATYR

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: